Physician profile
Brian M Parrett
NPI 1023196557
$11,503.18
in general payments reported to CMS, 2019-2025
13 companies · $1,592 in 2025
The $1,592 reported for 2025 was more than what 81% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,540 · 2020: $428 · 2021: $1,554 · 2022: $3,531 · 2023: $1,054 · 2024: $803 · 2025: $1,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,449.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $4,759.81 | 2019-2022 | |
| Abbvie INC. | $2,130.78 | 2023-2025 | |
| Sientra, INC. | $1,541.14 | 2020-2022 | |
| Kci USA, INC. | $904.10 | 2019 | |
| Integra Lifesciences Corporation | $552.53 | 2020-2023 | Durasorb Monofilament Mesh |
| Access Pro Medical, LLC | $467.91 | 2025 | Matriderm |
| Rti Surgical, INC | $433.72 | 2023-2025 | |
| Aroa Biosurgery Incorporated | $298.65 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $142.30 | 2022 | |
| Axogen | $129.80 | 2019-2023 | Avance Nerve Graft |
| Motiva USA, LLC | $61.91 | 2025 | |
| Derma Sciences, INC. | $52.54 | 2019 | |
| Acell, INC. | $27.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Parrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.